In September, Saama initiated a novel blog series, Clinical Trial Excellence for Tomorrow and Beyond, which proudly showcased the experience and expertise of the six newest members of Saama’s Clinical Board of Advisors. These stellar professionals offered insightful commentary and informed predictions about the current and future role AI-enabled data analytics will play in the life science industry’s ongoing clinical development efforts.
Throughout the series, two common themes emerged from these industry thought leaders. The first was the ongoing transformation of the clinical trial process, due in great part to the unprecedented quantities of data available to researchers. The second was the need to strategically and intelligently leverage this data via state-of-the-art analytics solutions to make clinical trial participation easier than ever before for patients and physicians, and the entire clinical trial process more efficient and effective. Without exception, each of our authors painted an exciting picture of the future promise and potential for clinical development.
Clinical Trial Excellence for Tomorrow and Beyond Blog Series Concluding Post Print
Modified on: Mon, 8 Feb, 2021 at 2:19 PM
Did you find it helpful? Yes No
Send feedbackSorry we couldn't be helpful. Help us improve this article with your feedback.